Healthtech Investors & VC Firms in France

104 firms in this list, with a median first check of $1M. 30 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
DA Danone Manifesto Venture CDHJACBR11 people	88🔒	New York City	US	Seed–Growth	—	+ Add to CRM
DE Debiopharm Innovation Fund MCTMTGVL13 people · Leads rounds	88🔒	Lausanne	CH	Pre-Seed–Late Stage	$1M – $5M	+ Add to CRM
FR Frst GDPEBRGG8 people · Follows rounds	88🔒	Paris	FR	Pre-Seed–Series B	$540K – $5.4M	+ Add to CRM
CA Capital Cell	88🔒	Barcelona	ES	Pre-Seed–Growth	—	+ Add to CRM
BR Brookstreet Equity Partners ODNBSPCS20 people	88🔒	London	GB	Pre-Seed–Growth	—	+ Add to CRM
LE LeadX Capital Partners HSJH2 people	88🔒	Munich	DE	Growth	$43.2M	+ Add to CRM
AM AMR Action Fund HSMHJGBB13 people	88🔒	Boston	US	Seed–Series C	—	+ Add to CRM
VE Vesper Infrastructure Partners AMGRGRLF16 people	88🔒	London	GB	Growth–Late Stage	—	+ Add to CRM
AU Auriga Partners JCCLGRMC15 people	88🔒	Paris	FR	Seed–Growth	$540K – $5.4M	+ Add to CRM
RE Red River West AVABLBOH7 people · Leads rounds	88🔒	Paris, Ile-De-France	FR	Seed–Growth	$5.4M – $54M	+ Add to CRM
GO GO Capital AMAMBDDL13 people	88🔒	Saint Jacques de la Lande	FR	Seed–Series B	$162K – $2.2M	+ Add to CRM
PU Pureos Bioventures DEKBMMVG11 people	88🔒	Pfäffikon	CH	Seed–Series C	—	+ Add to CRM
EU Eutopia VC AFCKJLMD4 people	88🔒	—	FR	Growth	$2.2M – $11M	+ Add to CRM
VE Verto ADTFAKLD9 people · Leads rounds	88🔒	Paris	FR	Growth	$16.2M – $64.8M	+ Add to CRM
GR GR Capital MFDLSKAL6 people · Follows rounds	88🔒	London	GB	Series A–Growth	$3.2M – $10.8M	+ Add to CRM
NO Novalis Biotech JVWVKMJB9 people	88🔒	Ghent	BE	Pre-Seed–Series A	—	+ Add to CRM
EL Elysia Capital MLSBFMFB7 people	88🔒	Turin	IT	—	—	+ Add to CRM
AN Angels Santé AJAGCMEP12 people	88🔒	Paris	FR	Pre-Seed–Series A	—	+ Add to CRM
PA PAI Partners AAAAEAEA8 people	88🔒	Paris	FR	Growth–Late Stage	$108M – $324M	+ Add to CRM
AE Aescap Life Sciences PKPDBJGH14 people	88🔒	Amsterdam	NL	Seed–Growth	—	+ Add to CRM
SO Sodero AACVMSRE11 people	88🔒	Nantes	FR	Seed–Late Stage	$162K – $5.4M	+ Add to CRM
EU Eurazeo LGLMMTNW12 people	88🔒	Paris	FR	Series A–Late Stage	—	+ Add to CRM
CO Connect Ventures PBRSSTMP4 people · Leads rounds	88🔒	London	GB	Pre-Seed–Series A	$500K – $5M	+ Add to CRM
VE Vesalius Biocapital III Partners SàRL CSGGMLCW12 people	88🔒	Contern	LU	Seed–Late Stage	$10.8M	+ Add to CRM

Danone Manifesto Venture

New York CitySeed–Growth

CDHJACBR11 people

Debiopharm Innovation Fund

LausannePre-Seed–Late Stage$1M – $5M

MCTMTGVL13 people

Frst

ParisPre-Seed–Series B$540K – $5.4M

GDPEBRGG8 people

Capital Cell

BarcelonaPre-Seed–Growth

Brookstreet Equity Partners

LondonPre-Seed–Growth

ODNBSPCS20 people

LeadX Capital Partners

MunichGrowth$43.2M

HSJH2 people

AMR Action Fund

BostonSeed–Series C

HSMHJGBB13 people

Vesper Infrastructure Partners

LondonGrowth–Late Stage

AMGRGRLF16 people

Auriga Partners

ParisSeed–Growth$540K – $5.4M

JCCLGRMC15 people

Red River West

Paris, Ile-De-FranceSeed–Growth$5.4M – $54M

AVABLBOH7 people

GO Capital

Saint Jacques de la LandeSeed–Series B$162K – $2.2M

AMAMBDDL13 people

Pureos Bioventures

PfäffikonSeed–Series C

DEKBMMVG11 people

Eutopia VC

Growth$2.2M – $11M

AFCKJLMD4 people

Verto

ParisGrowth$16.2M – $64.8M

ADTFAKLD9 people

GR Capital

LondonSeries A–Growth$3.2M – $10.8M

MFDLSKAL6 people

Novalis Biotech

GhentPre-Seed–Series A

JVWVKMJB9 people

Elysia Capital

Turin

MLSBFMFB7 people

Angels Santé

ParisPre-Seed–Series A

AJAGCMEP12 people

PAI Partners

ParisGrowth–Late Stage$108M – $324M

AAAAEAEA8 people

Aescap Life Sciences

AmsterdamSeed–Growth

PKPDBJGH14 people

Sodero

NantesSeed–Late Stage$162K – $5.4M

AACVMSRE11 people

Eurazeo

ParisSeries A–Late Stage

LGLMMTNW12 people

Connect Ventures

LondonPre-Seed–Series A$500K – $5M

PBRSSTMP4 people

Vesalius Biocapital III Partners SàRL

ConternSeed–Late Stage$10.8M

CSGGMLCW12 people

Data sourced from public filings and firms' own websites — see our methodology.